JP2023548307A5 - - Google Patents

Info

Publication number
JP2023548307A5
JP2023548307A5 JP2023526131A JP2023526131A JP2023548307A5 JP 2023548307 A5 JP2023548307 A5 JP 2023548307A5 JP 2023526131 A JP2023526131 A JP 2023526131A JP 2023526131 A JP2023526131 A JP 2023526131A JP 2023548307 A5 JP2023548307 A5 JP 2023548307A5
Authority
JP
Japan
Prior art keywords
powder composition
patient
composition according
dry powder
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023526131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548307A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/057078 external-priority patent/WO2022094100A1/en
Publication of JP2023548307A publication Critical patent/JP2023548307A/ja
Publication of JP2023548307A5 publication Critical patent/JP2023548307A5/ja
Pending legal-status Critical Current

Links

JP2023526131A 2020-10-28 2021-10-28 トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法 Pending JP2023548307A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063106818P 2020-10-28 2020-10-28
US63/106,818 2020-10-28
PCT/US2021/057078 WO2022094100A1 (en) 2020-10-28 2021-10-28 Dry powder compositions of treprostinil prodrugs and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023548307A JP2023548307A (ja) 2023-11-16
JP2023548307A5 true JP2023548307A5 (https=) 2024-11-07

Family

ID=81384296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023526131A Pending JP2023548307A (ja) 2020-10-28 2021-10-28 トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法

Country Status (9)

Country Link
US (2) US20240285570A1 (https=)
EP (1) EP4236934A4 (https=)
JP (1) JP2023548307A (https=)
KR (1) KR20230096998A (https=)
CN (1) CN116437906A (https=)
AU (1) AU2021369679A1 (https=)
CA (1) CA3196252A1 (https=)
MX (1) MX2023004812A (https=)
WO (1) WO2022094100A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2860975T3 (es) 2013-10-25 2021-10-05 Insmed Inc Compuestos de prostaciclina
CN114072136B (zh) 2019-04-29 2024-11-29 英斯梅德股份有限公司 曲前列素前药的干粉组合物及其使用方法
AU2024371435A1 (en) 2023-10-30 2026-04-23 Insmed Incorporated Medicament delivery device, cover, and methods of medicament delivery
WO2025147662A1 (en) * 2024-01-04 2025-07-10 Insmed Incorporated Methods of treatment using dry powder compositions of treprostinil prodrugs
WO2025230917A1 (en) * 2024-04-29 2025-11-06 Pharmosa Biopharm Inc. Methods for treating systemic sclerosis and frost bite by inhalation therapy

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
IT1240750B (it) 1990-04-12 1993-12-17 Chiesi Farma Spa Dispositivo per la somministrazione di sostanze medicamentose in polvere
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
DK0674533T3 (da) 1992-12-18 1999-09-27 Schering Corp Inhalator for medikamenter i pulverform
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
SE9302550D0 (sv) 1993-07-30 1993-07-30 Ernst Hoerlin Powder inhaler
PT101450B (pt) 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
FI95441C (fi) 1994-05-31 1996-02-12 Leiras Oy Inhalointilaitteen lääkeainekammio
FR2725626A1 (fr) 1994-10-18 1996-04-19 Sofab Dispositif pour l'inhalation de produits en poudre
SE9404439D0 (sv) 1994-12-21 1994-12-21 Astra Ab Inhalation device
ES2216418T3 (es) 1995-12-07 2004-10-16 Jago Research Ag Boquilla para un inhalador para la administracion de varias dosis de un polvo seco farmacologico.
US5797392C1 (en) 1996-01-22 2001-01-09 Direct Haler As Inhaler
US6026809A (en) 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
AU5719798A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
PT101988B (pt) 1997-04-04 2004-02-27 Hovione Farmaciencia Sa Sistema de orientacao e posicionamento de um objecto
GB9805102D0 (en) 1998-03-10 1998-05-06 Ciba Geigy Ag Device
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
WO1999066903A2 (en) 1998-06-24 1999-12-29 Advanced Inhalation Research, Inc. Large porous particles emitted from an inhaler
CA2341624C (en) 1998-08-25 2008-12-02 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
IT1309592B1 (it) 1999-03-05 2002-01-24 Chiesi Farma Spa Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
ATE363892T1 (de) 1999-03-05 2007-06-15 Chiesi Farma Spa Verbesserte pulverformulierungen zur inhalation
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
CA2400349C (en) 2000-03-10 2009-11-10 University Of North Carolina At Chapel Hill Dry powder inhaler devices, multi-dose dry powder drug packages, control systems, and associated methods
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
US20040102469A1 (en) 2002-09-13 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for reducing the mortality rate
GB0222023D0 (en) 2002-09-21 2002-10-30 Aventis Pharma Ltd Inhaler
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
ES2622471T5 (es) * 2003-05-22 2020-07-23 United Therapeutics Corp Compuestos y procedimientos para la administración de análogos de prostaciclina
ES2289221T3 (es) 2003-10-06 2008-02-01 BANG & OLUFSEN MEDICOM A/S Inhalador.
US8496002B2 (en) 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
ES2860975T3 (es) * 2013-10-25 2021-10-05 Insmed Inc Compuestos de prostaciclina
IL262720B2 (en) * 2016-05-05 2024-06-01 Liquidia Tech Inc Dry powder treprostinil for the treatment of pulmonary hypertension
MX2019006938A (es) * 2016-12-14 2019-09-06 Respira Therapeutics Inc Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon.
CA3102967A1 (en) * 2018-06-07 2019-12-12 Mannkind Corporation Composition and method for inhalation
CN114072136B (zh) 2019-04-29 2024-11-29 英斯梅德股份有限公司 曲前列素前药的干粉组合物及其使用方法
US20240238309A1 (en) * 2020-03-25 2024-07-18 Insmed Incorporated Pharmaceutical formulations of treprostinil prodrugs and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2023548307A5 (https=)
JP2022530637A5 (https=)
KR101653071B1 (ko) 선별적 s1p₁ 수용체 작동약에 대한 투약 섭생
EP0904097B1 (en) Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
MX2023004812A (es) Composiciones de polvo seco de profarmacos de treprostinil y metodos de uso de estos.
MX2024001929A (es) Composiciones de polvo seco de profarmacos de treprostinil y metodos de uso de las mismas.
EA004657B1 (ru) Фармацевтическая композиция на основе обладающих антихолинергическим действием соединений , способ ее получения и применение
JP2007532663A (ja) ニューロパシー性の糖尿病性足潰瘍を治療するためのトレプロスチニルの使用
JP2021514373A5 (https=)
CN1466463A (zh) 缺血性疾病治疗剂
JP2023522010A5 (https=)
JP2023512828A5 (https=)
JP2023519199A5 (https=)
EP4494701A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
EP4491183A1 (en) Use of hypoxanthine compound in preparation of drug for treating pulmonary fibrosis
JP2019531308A5 (https=)
JP7854206B2 (ja) 肺線維症の予防または治療用の薬学製剤
JP2016506417A5 (https=)
JP2021514380A5 (ja) 筋障害及び骨障害を処置するための化合物及び組成物
JP2024535596A5 (https=)
JP2023538125A5 (https=)
JP4784037B2 (ja) 塩酸ランジオロールを含有する頻脈性不整脈の治療剤
JP2009526817A5 (https=)
CN1703234A (zh) 低分子量凝血酶抑制剂的新用途
JP2005520832A5 (https=)